FDA has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Dec. 10, 2020 to discuss Pfizer and BioNTech’s emergency use authorization request for a COVID-19 vaccine.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/3pP9Qpp
No comments:
Post a Comment